Short- versus long-term dual antiplatelet therapy after second-generation drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials

被引:4
|
作者
Li, Hongqing [1 ]
Guo, Wenqin [1 ]
Dai, Weiran [1 ]
Li, Lang [1 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Cardiol, Guangxi Cardiovasc Inst, Nanning 530021, Guangxi, Peoples R China
来源
DRUG DESIGN DEVELOPMENT AND THERAPY | 2018年 / 12卷
关键词
dual antiplatelet therapy; second-generation drug-eluting stent implantation; meta-analysis; CORONARY-ARTERY-DISEASE; FOCUSED UPDATE; CLINICAL-TRIAL; DURATION; CLOPIDOGREL; EFFICACY; DISCONTINUATION; MULTICENTER; 6-MONTH; SAFETY;
D O I
10.2147/DDDT.S165435
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: The optimal dual antiplatelet therapy (DAPT) duration after second-generation drug-eluting stent (DES) implantation remains unclear. We aim to evaluate the efficacy and safety of short-term (<= 6 months) and long-term (>= 12 months) DAPT after second-generation DES implantation. Methods: Randomized controlled trials (RCTs) were searched in PubMed, the Cochrane Library, the Embase and ClinicalTrials.gov in the English language. The endpoints included all-cause mortality, cardiac death, non-cardiac death, myocardial infarction (MI), stent thrombosis (ST), stroke, all bleeding, and major bleeding. The effect estimate was expressed by using the hazard ratio (HR) with 95% CI and random effect models. Results: Seven RCTs with 13,571 patients were included in this study. In terms of survival endpoints, there was no significant difference in all-cause mortality (HR: 0.91; 95% CI: 0.71-1.17), cardiac death (HR: 0.93; 95% CI: 0.67-1.29), and non-cardiac death (HR: 0.89; 95% CI: 0.62-1.28) in the 2 groups. Moreover, there was no significant difference in ischemic outcomes, including MI (HR: 1.15; 95% CI: 0.91-1.45), ST (HR: 1.11; 95% CI: 0.75-1.66), and stroke (HR: 0.85; 95% CI: 0.53-1.35) in the 2 groups. In terms of bleeding endpoints, there was no significant difference in all bleeding (HR: 0.81; 95% CI: 0.64-1.04) and major bleeding (HR: 0.82; 95% CI: 0.49-1.36) in the 2 groups. The subgroup analysis showed that the proportion of patients with acute coronary syndrome was not associated with the benefit of long-term versus short-term DAPT. Conclusion: Short-term DAPT is not inferior to long-term DAPT in patients implanted with second-generation DES.
引用
收藏
页码:1815 / 1825
页数:11
相关论文
共 50 条
  • [31] Clinical Outcomes of Very Short Term Dual Antiplatelet Therapy in Patients With or Without Diabetes Undergoing Second-Generation Drug-Eluting Stents: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
    Liang, Xi-Ying
    Li, Yan
    Qiao, Xuan
    Zhang, Wen-Jiao
    Wang, Zhi-Lu
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [32] Benefits and risks of long-term duration of dual antiplatelet therapy after drug-eluting stenting: A meta-analysis of randomized trials
    Valgimigli, Marco
    Park, Seung-Jung
    Kim, Hyo-Soo
    Park, Kyung Woo
    Park, Duk-Woo
    Tricoci, Pierluigi
    Ferrante, Giuseppe
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (03) : 2579 - 2587
  • [33] BENEFITS AND RISKS OF LONG-TERM DURATION OF DUAL ANTIPLATELET THERAPY AFTER DRUG-ELUTING STENTING: A META-ANALYSIS OF RANDOMIZED TRIALS
    Ferrante, G.
    Park, S. J.
    Kim, H. S.
    Park, K. W.
    Park, D. W.
    Valgimigli, M.
    CARDIOLOGY, 2013, 125 : 425 - 425
  • [34] Influence of dual antiplatelet therapy duration on neointimal condition after second-generation drug-eluting stent implantation
    Yutaka Goryo
    Teruyoshi Kume
    Hiroshi Okamoto
    Ai Kawamura
    Kenzo Fukuhara
    Tomoko Tamada
    Terumasa Koyama
    Koichiro Imai
    Ryotaro Yamada
    Yoji Neishi
    Shiro Uemura
    Cardiovascular Intervention and Therapeutics, 2022, 37 : 101 - 108
  • [35] Influence of dual antiplatelet therapy duration on neointimal condition after second-generation drug-eluting stent implantation
    Goryo, Yutaka
    Kume, Teruyoshi
    Okamoto, Hiroshi
    Kawamura, Ai
    Fukuhara, Kenzo
    Tamada, Tomoko
    Koyama, Terumasa
    Imai, Koichiro
    Yamada, Ryotaro
    Neishi, Yoji
    Uemura, Shiro
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2022, 37 (01) : 101 - 108
  • [36] Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six-Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy
    Tarantini, Giuseppe
    Fovino, Luca Nai
    Tellaroli, Paola
    Chieffo, Alaide
    Barioli, Alberto
    Menozzi, Alberto
    Frasheri, Arian
    Garbo, Roberto
    Masotti-Centol, Monica
    Salvatella, Neus
    Oteo Dominguez, Juan Francisco
    Steffanon, Luigi
    Presbitero, Patrizia
    Pucci, Edoardo
    Fraccaro, Chiara
    Mauri, Josepa
    Giustino, Gennaro
    Sardella, Gennaro
    Colombo, Antonio
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 207 : 168 - 176
  • [37] Shorter (≤6 months) vs. longer (≥12 months) dual antiplatelet therapy after second-generation drug-eluting stents implantation: a meta-analysis of randomized controlled trials
    Huang, He
    Li, Ya
    Sun, Meina
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2016, 18 (0A) : A54 - A62
  • [38] SHORT VERSUS LONG DURATION OF DUAL ANTIPLATELET THERAPY AFTER SECOND GENERATION DRUG-ELUTING STENTS IMPLANTATION IN DIABETICS
    Gangwani, Manesh Kumar
    Aziz, Abeer
    Sagheer, Shazib
    Ahuja, Priyanka
    Lee-Smith, Wade
    Aziz, Muhammad
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 129 - 129
  • [39] Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Sharma, Abhishek
    Garg, Aakash
    Elmariah, Sammy
    Drachman, Douglas
    Obiagwu, Chukwudi
    Vallakati, Ajay
    Sharma, Samin K.
    Lavie, Carl J.
    Mukherjee, Debabrata
    Waksman, Ron
    Stefanini, Giulio G.
    Feres, Fausto
    Marmur, Jonathan D.
    Helft, Gerard
    PROGRESS IN CARDIOVASCULAR DISEASES, 2018, 60 (4-5) : 500 - 507
  • [40] SHORT-TERM VERSUS LONG-TERM DUAL ANTIPLATELET THERAPY AFTER DRUG-ELUTING STENTING IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Silveira, Giullia
    De Paula Carvalho, Pedro Emanuel
    Macedo, Harthur Moreira
    Goncalves, Livian De Sousa
    Seixas Rangel Maciel, Anna Carolina Fontoura
    Gomes, Wilton Francisco
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1222 - 1222